Rationale and design of the dal-OUTCOMES trial: Efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome

✍ Scribed by Gregory G. Schwartz; Anders G. Olsson; Christie M. Ballantyne; Phillip J. Barter; Ingar M. Holme; David Kallend; Lawrence A. Leiter; Eran Leitersdorf; John J.V. McMurray; Prediman K. Shah; Jean-Claude Tardif; Bernard R. Chaitman; Regina Duttlinger-Maddux; John Mathieson

• Book ID: 116191921
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 191 KB
• Volume: 158
• Category: Article
• ISSN: 1097-6744
• DOI: 10.1016/j.ahj.2009.09.017